Clinical Trials for Cutaneous T-Cell Lymphoma (CTCL)
Cutaneous T-cell lymphoma (CTCL), including mycosis fungoides and Sézary syndrome, is a rare type of non-Hodgkin lymphoma that primarily affects the skin. Clinical trials offer access to new treatments including novel targeted therapies, immunotherapies, and combination approaches.
Live from our database
TrialCompass currently tracks 153 curated clinical trials for CTCL
What types of CTCL trials are available?
Trials are grouped by where you are in your treatment journey.
Newly diagnosed
Frontline trials evaluate new combinations and targeted agents added to (or replacing) standard first-line therapy.
Relapsed / refractory
Trials for disease that returned or did not respond, including novel targeted therapies, antibody-drug conjugates, and cellular therapies.
Maintenance / remission
Studies of consolidation or maintenance strategies aimed at keeping the disease from returning after a response.
How to use TrialCompass
- 1Browse CTCL trials and use the sidebar filters to narrow by treatment stage, phase, or U.S. state.
- 2Ask the AI Assistant a plain-language question — it searches only trials curated by our hematology specialist.
- 3Generate a letter to bring trials of interest to your oncology team for eligibility review.
Related resources
For completeness, you can also search the U.S. federal registry at ClinicalTrials.gov. TrialCompass curates a physician-selected subset so patients don't have to sift through hundreds of listings.